Gene Biotherapeutics, Inc. (5)
Browse by Contract Category
Contracts
-
Preferred Stock Purchase Agreement dated May 22, 2020 for the purchase of Series B Convertible Preferred Stock
(Filed With SEC on May 28, 2020)
-
Reaffirmation and Ratification Agreement dated April 10, 2020 between Gene Biotherapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd
(Filed With SEC on May 28, 2020)
-
Distribution and License Agreement dated April 10, 2020 between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd
(Filed With SEC on May 28, 2020)
-
Amendment No. 1 to Distribution and License Agreement dated April 14, 2020 between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd
(Filed With SEC on May 28, 2020)
-
License and Patent Assignment Agreement dated April 10, 2020 between Activation Therapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd
(Filed With SEC on May 28, 2020)